Postoperative gastrointestinal dysfunction
Conditions
Interventions
Control Group:The standard ERAS pathway SOP requires both groups of participants to strictly follow the following core ERAS measures:
Preoperatively: Drink 200–400ml of carbohydrate fluids 2 hours bef
goal-directed fluid management
continuous intraoperative temperature monitoring and maintaining above 36?.
Postoperatively: Remove the gastric tube as soon as the vital signs are stable (within 6 hours after surgery)
complete bedside sitting or getting out of bed activities within 24 hours after surgery
attempt to drink small amounts of water (30–50ml) within 24 hours after surgery, gradually transitioning to solid food based on tolerance.
Experimental Group:Experimental group: ERAS pathway + Traditional Chinese Medicine Acupoint Application SOP. In addition to the above ERAS measures, add the application of traditional Chinese medicine
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Age and Gender: 18–75 years old, gender not restricted. 2. Surgical Type: Planned to undergo elective liver, biliary tract or pancreatic surgery in hepatobiliary and pancreatic surgery department (open surgery or minimally invasive surgery are both acceptable). 3. Definition of Major Surgery: According to expert opinions, it is defined as surgeries with an expected duration of >= 3 hours. 4. Anesthesia Grade: American Society of Anesthesiologists (ASA) grade I–III. 5. Management Pathway: Preoperative assessment meets the conditions for ERAS (Enhanced Recovery After Surgery) pathway management. 6. Communication and Informed Consent: Has basic communication skills and can complete follow-up and scale filling; Voluntarily participates in this study and signs a written informed consent form.
Exclusion criteria
Exclusion criteria: 1. Nature of the surgery: Emergency surgery or surgeries involving multiple organ combinations that need to be performed simultaneously. 2. Baseline motility disorder: Patients with preoperative confirmed intestinal obstruction, severe gastrointestinal motility disorders, or inflammatory bowel disease (IBD). 3. Severe comorbidities: Complications such as severe cardiac dysfunction (NYHA III-IV grade), respiratory failure, liver failure (Child-Pugh C grade), and renal failure (requiring dialysis). 4. Intraoperative variables: Intraoperative uncontrollable massive bleeding or severe complications that prevent the implementation of the ERAS process. 5. Local skin limitations: Skin at the acupoint application area (Shenque acupoint) is ulcerated, infected, has severe eczema, or has a clear history of allergy to the application ingredients. 6. Special populations: Pregnant or lactating women; individuals with severe mental illness or cognitive impairment who cannot cooperate. 7. Other interference: Participants who are concurrently participating in other clinical trials that may interfere with the evaluation of the main outcome of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recovery time;The incidence of postoperative intestinal paralysis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical recovery indicators;Symptom score;30 day postoperative complication rate; | — |
Countries
China
Contacts
Public ContactHuiming Lu
West China Hospital, Sichuan University
Outcome results
None listed